Oculus secures U.S. patent for skin ulcer technology

12/28/2012 | MedCityNews.com

Oculus Innovative Sciences has received a U.S. patent for its Microcyn Technology to be used in treating patients with skin ulcers. The technology is administered to skin ulcers either by irrigation, soaking and washing, or by applying a wound dressing that has been soaked with the technology.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Affairs Specialist
Becton Dickinson
Franklin Lakes, NJ
Customer Service Director
UCare
Minneapolis, MN
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Behavioral Health Operations Director
UCare
Minneapolis, MN
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID